Home/Filings/4/0001104659-21-005312
4//SEC Filing

Altarac David 4

Accession 0001104659-21-005312

CIK 0001724344other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:06 PM ET

Size

4.5 KB

Accession

0001104659-21-005312

Insider Transaction Report

Form 4
Period: 2021-01-15
Altarac David
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-01-15+25,00025,000 total

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001792615

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:06 PM ET
Size
4.5 KB